NL-OMON21253招募中不适用
Biomarkers in Atopic Dermatitis, The Netherlands
Amsterdam UMC, Academic Medical Center0 个研究点目标入组 110 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patient has a diagnosis of AD, based on the U.K. working party’s diagnostic criteria;
- •-Starts with any type of phototherapy (e.g. UVB) or systemic immunomodulating therapy (e.g. ciclosporin, systemic glucocorticosteroids, azathioprine, methotrexate, mycophenolic acid, dupilumab);
- •-Has voluntarily signed and dated an informed consent prior to any study related procedure or has a legal representative to do so and is willing to comply with the requirements of this study protocol.
排除标准
- •-Patient uses only (systemic) antibiotics or antihistamines;
- •-Patient starts with systemic immunomodulating therapy for another indication than atopic dermatitis;
- •-Insufficient understanding of the study by the patient or parent/legal representative;
- •-Patient does not participate in the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
研究者
相似试验
已完成
不适用
Biomarkers in Atopic Dermatitis and Psoriasis The Netherlandsatopic eczema10014982Atopic dermatitisNL-OMON48036Academisch Medisch Centrum110
进行中（未招募）
不适用
AMBITIOUSAtopic Dermatitis Biomarker Identification Trial in Omalizumab UsageSingle- arm trial to identify potential markers underlying variability in response to Omalizumab (Xolair®) treatment in atopic dermatitis - AMBITIOUSAMBITIOUS is a trial to identify potential markers underlying variability in response to Omalizumab (Xolair®) treatment in atopic dermatitisAtopische Dermatitis is a common inflammatory skin disease showing chronically relapsing eczema and high association with elevated serum IgE levels.MedDRA version: 14.0Level: LLTClassification code 10029264Term: Neurodermatitis aggravatedSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2010-018559-84-DEMedizinische Fakultät der technischen Universität Muenchen20
已完成
不适用
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)Dermatitis AtopicNCT03849716Sanofi266
已完成
不适用
Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trialAtopic dermatitisJPRN-UMIN000041204Takashima Clinic57
招募中
不适用
EVALUATION OF BIOMARKERS OF ATOPIC DERMATITIS IN PEDIATRIC PATIENTS WHOSE DISEASE IS NOT ADEQUATELY CONTROLLED WITH TOPICAL PRESCRIPTION THERAPIES OR WHEN THOSE THERAPIES ARE NOT MEDICALLY ADVISABLEatopic dermatitisNL-OMON48261Sanofi-aventis12